Why Magic Mushrooms Could Overshadow the Cannabis Boom
Tue January 14, 2020
Houston, Texas--(Newsfile Corp. - January 14, 2020) - MarijuanaStox announces publication of an article that discusses The Yield Growth Corporation (CSE: BOSS) (OTCQB: BOSQF). The company has been aggressively addressing demand for health, wellness, and beauty products infused with premium-cannabis and hemp-based products internationally with subsidiary, Urban Juve in addition to psilocybin mushrooms.
Psilocybin Mushrooms Offering Major Breakthrough for Mental Health
Psilocybin Mushrooms are offering sizable breakthroughs for a myriad of mental health issues.
In fact, we're already seeing a groundswell of interest, as mushrooms become a promising candidate for anxiety and depression because it, "Appears to disrupt the sorts of engrained brain activity patterns that are the hallmark of those diseases," says Business Insider.
Other studies are looking at psilocybin mushroom's effect on anxiety, PTSD, and alcoholism.
Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post, for example.
Psychiatrists at Johns Hopkins University even found that mushrooms can help with smoking cessation, and another study found it can assist with alcohol dependence.
Better, researchers from the University of California David found that micro-dosing with psychedelic drugs for a prolonged period of time showed promise. "Our study demonstrates that psychedelics can produce beneficial behavioral effects without drastically altering perception, which is a critical step towards producing viable medicines inspired by these compounds," said David Olson of UC Davis, as quoted by Esquire.
Another study in the Journal of Psychopharmacology found that a single mushroom-based treatment can help improve the lives of cancer patients' quality of life for nearly five years. This study builds on a 2016 study that provided treatments to 29 people suffering with life-threatening cancer, and were also diagnosed with depression or anxiety.
Of the 16 surviving participants from that study, 15 participated in a follow-up study, which found "reductions in anxiety, depression, hopelessness, demoralization, and death anxiety were sustained" for nearly five years, as reported by IFL Science.
But this is just the start of a bigger story.
As researchers see further benefits of psilocybin mushrooms for the treatment of mental health issues, it's already creating sizable investment opportunities.
Yield Growth Corporation is a Major Beneficiary of Mushroom Boom
To date, Yield Growth has made substantial headway with the mushroom story.
In late 2019, for example, the company's wholly-owned subsidiary Flourish Mushroom Labs Inc. completed the acquisition of a catalogue of mushroom formulas as the foundation of a mushroom edibles business. The formulas and know-how acquired relate to formulations that may be used to create ready to eat packaged food products or packaged food products that may be mixed with mushroom varietals of the consumer's choice.
The formulations include soups, teas, hot cocoa, elixirs and truffles. Flourish has engaged the developers to create additional products to add to the base catalogue and commercialize the formulas, going to market first with mushroom based soups and coffees.
The subsidiary also completed initial development of a mushroom coffee formula, and will launch a new line of mushroom-infused coffee mixes, infused with various wild mushrooms such as Lion's Mane, Turkey Tail, Reishi, Shitake, Chagas and Cordyceps.
"Our research indicates that edible mushrooms are in a period of high growth," says Yield Growth CEO Penny White. "Yield Growth intends to add to its cannabis wellness assets through acquisitions in companies. Edible Mushrooms may experience hyper-growth as the movement to decriminalize psilocybin (magic mushrooms) grows, similar to how the popularity of hemp has grown with the legalization of cannabis."
Other than infused-coffee, the subsidiary entered into an agreement to license 126 formulas based on ancient Ayurvedic medicine to its wholly owned subsidiary Flourish Mushroom Labs for use in products infused with functional or magic mushrooms for a 50 year term.
Licensed formulas include skin care formulas such as face masks, body oils, creams, face oils, exfoliants, food and beverages formulas such as teas, ayurvedic herbal blend formulas, and other wellness formulas for the purpose of developing, manufacturing, marketing and selling products worldwide, excluding Canada.
The formulas may be used in foods, beverages, personal care, skin care, cosmetic and other wellness products that are infused with functional mushrooms or psilocin or psilocybin (magic mushrooms) or any combination thereof.
As the story begin to pick up momentum, companies like Yield Growth will be major beneficiaries. For more information, visit the company's website at https://yieldgrowth.com.
https://seekingalpha.com/pr/17748421-why-magi...nabis-boom
Tue January 14, 2020
Houston, Texas--(Newsfile Corp. - January 14, 2020) - MarijuanaStox announces publication of an article that discusses The Yield Growth Corporation (CSE: BOSS) (OTCQB: BOSQF). The company has been aggressively addressing demand for health, wellness, and beauty products infused with premium-cannabis and hemp-based products internationally with subsidiary, Urban Juve in addition to psilocybin mushrooms.
Psilocybin Mushrooms Offering Major Breakthrough for Mental Health
Psilocybin Mushrooms are offering sizable breakthroughs for a myriad of mental health issues.
In fact, we're already seeing a groundswell of interest, as mushrooms become a promising candidate for anxiety and depression because it, "Appears to disrupt the sorts of engrained brain activity patterns that are the hallmark of those diseases," says Business Insider.
Other studies are looking at psilocybin mushroom's effect on anxiety, PTSD, and alcoholism.
Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post, for example.
Psychiatrists at Johns Hopkins University even found that mushrooms can help with smoking cessation, and another study found it can assist with alcohol dependence.
Better, researchers from the University of California David found that micro-dosing with psychedelic drugs for a prolonged period of time showed promise. "Our study demonstrates that psychedelics can produce beneficial behavioral effects without drastically altering perception, which is a critical step towards producing viable medicines inspired by these compounds," said David Olson of UC Davis, as quoted by Esquire.
Another study in the Journal of Psychopharmacology found that a single mushroom-based treatment can help improve the lives of cancer patients' quality of life for nearly five years. This study builds on a 2016 study that provided treatments to 29 people suffering with life-threatening cancer, and were also diagnosed with depression or anxiety.
Of the 16 surviving participants from that study, 15 participated in a follow-up study, which found "reductions in anxiety, depression, hopelessness, demoralization, and death anxiety were sustained" for nearly five years, as reported by IFL Science.
But this is just the start of a bigger story.
As researchers see further benefits of psilocybin mushrooms for the treatment of mental health issues, it's already creating sizable investment opportunities.
Yield Growth Corporation is a Major Beneficiary of Mushroom Boom
To date, Yield Growth has made substantial headway with the mushroom story.
In late 2019, for example, the company's wholly-owned subsidiary Flourish Mushroom Labs Inc. completed the acquisition of a catalogue of mushroom formulas as the foundation of a mushroom edibles business. The formulas and know-how acquired relate to formulations that may be used to create ready to eat packaged food products or packaged food products that may be mixed with mushroom varietals of the consumer's choice.
The formulations include soups, teas, hot cocoa, elixirs and truffles. Flourish has engaged the developers to create additional products to add to the base catalogue and commercialize the formulas, going to market first with mushroom based soups and coffees.
The subsidiary also completed initial development of a mushroom coffee formula, and will launch a new line of mushroom-infused coffee mixes, infused with various wild mushrooms such as Lion's Mane, Turkey Tail, Reishi, Shitake, Chagas and Cordyceps.
"Our research indicates that edible mushrooms are in a period of high growth," says Yield Growth CEO Penny White. "Yield Growth intends to add to its cannabis wellness assets through acquisitions in companies. Edible Mushrooms may experience hyper-growth as the movement to decriminalize psilocybin (magic mushrooms) grows, similar to how the popularity of hemp has grown with the legalization of cannabis."
Other than infused-coffee, the subsidiary entered into an agreement to license 126 formulas based on ancient Ayurvedic medicine to its wholly owned subsidiary Flourish Mushroom Labs for use in products infused with functional or magic mushrooms for a 50 year term.
Licensed formulas include skin care formulas such as face masks, body oils, creams, face oils, exfoliants, food and beverages formulas such as teas, ayurvedic herbal blend formulas, and other wellness formulas for the purpose of developing, manufacturing, marketing and selling products worldwide, excluding Canada.
The formulas may be used in foods, beverages, personal care, skin care, cosmetic and other wellness products that are infused with functional mushrooms or psilocin or psilocybin (magic mushrooms) or any combination thereof.
As the story begin to pick up momentum, companies like Yield Growth will be major beneficiaries. For more information, visit the company's website at https://yieldgrowth.com.
https://seekingalpha.com/pr/17748421-why-magi...nabis-boom
